Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine

Translational Research

Volumn 149, Issue 2, 2007, Pages 55-61

  Subbiah, M T Ravi ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN A1; APOLIPOPROTEIN E; FOLIC ACID; LEPTIN RECEPTOR; NUTRACEUTICAL;

ALTERNATIVE MEDICINE; BOTANY; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DIET; DIET SUPPLEMENTATION; DIETETICS; FOLATE METABOLISM; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN GENOME PROJECT; NUTRIGENOMICS; OBESITY; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

EID: 33846214691     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.09.003     Document Type: Review

References (73)

1. Venter J.C., Adams M.D., Myers E.W., Peter W., Mural R.J., Sutton G.G., et al. The sequence of human genome. Science 291 (2001) 1304-1351
2. Debusk R.M., Fogarty C.P., Ordovas J.M., and Kornman K.S. Nutritional genomics in practice: where do we begin?. J Amer Diet Assoc 105 (2005) 589-598
3. Stover P.J. Influence of human genetic variation on nutritional requirements. Amer J Clin Nutr 83 suppl (2006) 436S-442S
4. Menedez J.A., Vellon L., Colomer R., and Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil suppresses her-2/neu (erb-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol 16 (2005) 359-371
5. Kitajka K., Sinclair A.J., Weisinger R.S., Weisinger H.S., Mathai M., Jayasooriya A.P., et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci 101 (2004) 10931-10936
6. Huang W., Wood C., L'Abbe M.R., Gilani G.S., Cockell K.A., and Xiao C.W. Soy protein isolate increase hepatic thyroid hormone receptor content and inhibits its binding to target genes in rats. J Nutr 135 (2005) 1631-1635
7. Mezei O., Li Y., Mullen E., Ross-Viola G.S., and Shay N.F. Dietary isoflavone supplementation modulates lipid metabolism via PPAR(alpha) dependent and independent mechanisms. Physiol Genomics (2006) Epub Feb 28
8. Shay N.F., and Banz W.J. Regulation of gene transcription by botanicals: novel regulatory mechanisms. Ann Rev Nutr 25 (2005) 297-315
9. Vissac-Sabatier C., Bignon Y.J., and Bernard-Gallon D.J. Effects of phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cancer cell lines. Nutr Cancer 45 (2003) 247-255
10. Rimbach G., Wolffram S., Watanabe C., Packer L., and Gohil K. Effect of Ginko biloba (EGb 761) on differential gene expression. Pharmacopsychiatry 36 suppl (2003) S95-S99
11. Peshel D., Koerting R., and Nass N. Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem (2006) Epub May 16
12. Zheng S., and Chen A. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Amer J Physiol (Gastrointest Liver Physiol) 290 (2005) G883-G893
13. Young L.F., and Martin K.R. Time dependent resveratrol mediated mRNA and protein expression associated with cell cycle in WR-21 cells containing mutated human c-Ha-Ras. Mol Nutr Food Res 50 (2006) 70-77
14. Aoshima H., Okita Y., Hossain S.J., Fukue K., Mito M., Orihara Y., et al. Effect of 3-O-octanyl-catechin on the response of GABA(A) receptors and Na+/glucose co-transporters expressed in xenopus oocytes and on the oocyte membrane potential. J Agric Food Chem 53 (2005) 1955-1959
15. Del Bas J.M., Fernandez-Larrea J., Blay M., Ardevol A., Salvado M.J., Arola L., et al. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats. FASEB J 19 (2005) 479-481
16. Noe V., Penuelas S., Lammuela-Reventos R.M., Permanyer J., Ciudad C.U., and Izquierdo-Pulido M. Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2 cells. J Nutr 134 (2004) 2509-2516
17. Marambaud P., Zhao H., and Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280 (2005) 37377-37382
18. Frosst P., Blom H.J., Milos R., Goyette R., Shepherd C.A., Mathews R.G., et al. A candidate for genetic risk factor for vascular disease: common mutation in methylene tetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
19. Reyes-Engel A., Munoz E., Gaitan M.J., Fabre E., Gallo M., Dieguez J.L., et al. Implication on the human fertility of the 677C to T and 1298A to C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Human Reprod 8 (2002) 952-957
20. Hanson H.Q., Aras O., Yang F., and Tsai M.Y. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47 (2001) 661-666
21. Guieterez Revilla J.I., Parez Hernandez F., Calvo Martin M.T., Tamparillas Salvador M., and Gracia Romero J. C677T and A1298C MTHFR polymorphisms in the etiology of neural tube defects in Spanish population. Med Clin (Barc) 120 (2003) 441-445
22. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural tube defects by peri- conceptional vitamin supplementation. N Engl J Med 327 (1992) 1832-1835
23. Molloy A.M., and Scott J.M. Folates and prevention of disease. Public Health Nutr 4 (2001) 601-609
24. Loktionov A. Common gene polymorphisms and nutrition: emerging links with pathogenesis of mutifactorial chronic diseases. J Nutr Biochem 14 (2003) 426-451
25. Ordovas J.M., and Schaefer E.J. Genetic determinants of plasma lipid response to dietary intervention: the role of the ApoA1/C3/A4 gene cluster and APOE gene. Br J Nutr 83 suppl 1 (2000) S127-S136
26. Loctionov A., Scollen C., McKeowan N., and Bingham S.A. Gene-Nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E ε{lunate}4 carrying free living individuals. Br J Nutr 84 (2000) 885-890
27. Corella D., Tucker K., Lahoz C., Coltel O., Cupples L.A., Wilson P.W., et al. Alcohol drinking determines the effect of of the APOE locus on LDL concentrations in men: The Framingham Offspring Study. Amer J Clin Nutr 73 (2001) 736-745
28. Ordovas J.M., Corella D., Cupples L.A., Demissie S., Kelleher A., Coltel O., et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL cholesterol concentrations in a sex specific manner. The Framingham Study. Amer J Clin Nutr 75 (2002) 38-46
29. Ordovas J.M., Corella D., and Demissie S. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high density lipoprotein metabolism: evidence of a strong effect in this gene-nutrient interaction in Framingham Study. Circulation 106 (2002) 2315-2321
30. Li W.D., Reed D.R., Lee J.H., Xu W., Kilker R.L., Sodom B.R., et al. Sequence variants in the 5'flanking region of the leptin gene are associated with obesity in women. Ann Human Genet 63 (1999) 227-234
31. Mammes O., Betoulle D., Aubert R., Herpath B., Siest G., and Fumeron F. Association of the G2548A polymorphism in the 5' region of the LEP gene with overweight. Ann Human Genet 64 (2000) 391-394
32. Chagnon Y.C., Wilmore J.H., Borecki I.B., Gagnon J., Perusse L., Chagnon M., et al. Associations between the leptin receptor gene and adiposity in middle aged Caucasian males from the HERITAGE family study. J Clin Endo Met 85 (2000) 29-34
33. Wauters M., Mertens I., Chagnon M., Raniken T., Considine R.V., Chagnon Y.C., et al. Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obesity 25 (2001) 714-720
34. Dubern B., Clement K., Pelloux V., Froguel P., Girardet J.P., Guy-Grand B., et al. Mutational analysis of melanocortin-4-receptor, agouti related protein and alpha melanostimulating hormone genes in severely obese children. J Pediatr 139 (2001) 204-209
35. Chagnon Y.C., Chen W.J., Perusse L., Chagnon M., Nadeau A., Wilkinson W.O., et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity related phenotypes in the Quebec Family Study. Mol Med 3 (1997) 663-673
36. Jenkinson C.P., Cray K., Walder K., Herzog H., Hanson R., and Ravussin E. Novel polymorphisms in the neuropeptide -Y Y5 receptor associated with obesity in Pima Indians. Int J Obesity 24 (2000) 580-584
37. Sloan A.E. The top 10 functional food trends: the next generation. Food Tech 56 (2002) 32-57
38. Buchman A.L. Personal and government regulation of nutritional supplements: what we want and what we should expect. J Lab Clin Med 139 (2002) 339-342
39. Koretz R.L. Is alternative medicine alternative science?. J Lab Clin Med 139 (2002) 329-333
40. Cronin J.R. Dietary supplements: safety, certification, labeling and efficacy. Alternat Compliment Ther 8 (2002) 141-148
41. Chan M. Herbal medicines: what work and how to use them safely. The Ohio Family Physician (Fall) 20 (2003) 2360
42. Wojcikowski K., Johnson D.W., and Gobe G. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med 147 (2006) 160-166
43. Henman A.R. Guarana (Paullinia cupana var sorbilis): ecological and social perspectives on an economic plant of the Central Amazon Basin. J Ethnopharmacol 6 (1982) 311-338
44. Bydlowski S.P., Yunker R.L., and Subbiah M.T.R. A novel property of aqueous guarana extract (Paullinia cupana): inhibition of platelet aggregation. Braz. J Med Biol Res 21 (1988) 535-538
45. Bydlowski S.P., D'Amico E.A., and Chamone D.A. An aqueous extract of guarana (Paullinia cupana) decreases platelet thromboxane synthesis. Braz J Med Biol Res 24 (1991) 421-424
46. Tanis B.C., and Rosendaal F.R. Venous and arterial thrombosis during oral contraceptive use: risk and risk factors. Semi Vasc Med 3 (2003) 69-84
47. Rosendaal F.R., Van Hylckama V.A., Tanis B.C., and Helmerhorst F.M. Estrogens, progestogens and thrombosis. J Thromb Haemost 1 (2003) 1371-1380
48. Mohllajee A.P., Curtis K.M., Martins S.L., and Peterson H.B. Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism?. A systematic review. Contraception 73 (2005) 166-178
49. Vaya A., Mira Y., Mateo J., Falco C., Villa P., Estelles A., et al. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thromb Haemost 89 (2003) 452-457
50. Legnani C., Cini M., Cosmi B., Poggi M., Boggian O., and Palareti G. Risk of deep vein thrombosis: interaction between oral contraceptives and higher factor VIII levels. Haematologia 89 (2004) 1347-1351
51. Kemmeren J.M., Algra A., Meijers J.C., Tans G., Bouma B.N., Curvers J., et al. Effect of second and third generation oral contraceptives on protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial. Blood 104 (2004) 927-933
52. Heinemann L.A., Lewis M.A., Spitzer W.O., Thorogood M., Gugggenmoos-Holzman I., and Bruppacher R. Thromboembolic stroke in young women. A European case-controlled study on oral contraceptives. Translational research group on oral contraceptives and the the health of young women. Contraception 57 (1998) 29-37
53. Wassertheil-Smoller S., Hendrix S.L., Limacher M., Heiss G., Kooperberg C., Baird A., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 289 (2003) 271-279
54. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory study: a randomized controlled trial. JAMA 289 (2003) 2717-2719
55. Bath P.A., and Gray L.J. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. British Med J 330 (2005) 342-344
56. Cushman M., Kuller L.H., Prentice R., Rodabough R.J., Psaty B.M., Stafford R.S., et al. Estrogen plus progestin and risk of venous thrombosis. JAMA 292 (2004) 1573-1580
57. Smith N.L., Heckbert S.R., Lemaitre R.N., Reiner A.P., Lumley T., Weis N.S., et al. Esterified estrogens and conjugated equine estrogens and risk of venous thrombosis. JAMA 292 (2004) 1581-1587
58. Hulley S., Grady D., and Bush T. Heart and Estrogen/progestin Replacement Study (HERS). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-612
59. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Eng J Med 343 (2000) 522-529
60. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized Controlled Trial. JAMA 288 (2002) 321-333
61. Glueck C.J., Wang P., Fontaine R.N., Tracy T., Sieve-Smith L., and Lang J.E. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the Factor V Leiden mutation. Amer J Cardiol 84 (1999) 549-554
62. Glueck C.J., Wang P., Fontaine R.N., Sieve-Smith L., and Lang J.E. Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: a cross-sectional study of 275 hyperlipidemic women. Metabolism 50 (2001) 360-365
63. Psaty B.M., Smith N.L., Lemaitre R.N., Vos H.L., Heckbert S.R., LaCoix A., et al. Hormone replacement therapy, prothrombotic mutations and the risk of incident non-fatal myocardial infarction in postmenopausal women. JAMA 285 (2001) 906-913
64. Gardemann A., Lohre J., Katz N., Tillmans H., Hehrlein F.W., and Haberbosch W. The 4G/4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for the disease. Thromb Heamost 82 (1999) 1121-1126
65. Lanas A., Garcia-Rodriguez L.A., Arroyo M.T., Gomollon F., Feu F., Gonzales Parez A., et al. Risk of upper gastrointestinal bleeding associated with selective COX-2 inhibitors, traditional NSAIDs, aspirin and combinations. Gut (2006) Epub May 10
66. Houghton P. Guarana. Pharmaceutical J 254 (1995) 435-436
67. Subbiah M.T.R. Guarana consumption. A review of health benefits and risks. Altern Compliment Ther 4 (2005) 212-213
68. Wagner D.D., and Burger P.C. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23 (2003) 2131-2137
69. Subbiah M.T.R. Long term effects of hormone replacement therapy. Lancet 361 (2003) 255
70. Kumar D., and Jugdutt B.I. Apoptosis and oxidants in the heart. J Lab Clin Med 142 (2003) 288-297
71. Corella D., Qi L., Tai E.S., Deurenberg-Yap M., Tan C.E., Chew S.K., et al. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high saturated fat, low carbohydrate diet. Diabetes Care 29 (2006) 1313-1319
72. Shen H., Tai E.S., Chew S.K., Tan C.E., and Ordovas J.M. Uncoupling protein 2 promotor polymorphism -866G/A, central adiposity and metabolic syndrome in Asians. Obesity 14 (2006) 656-661
73. Herron K.L., McGrane M.M., Waters D., Lofgren I.E., Clark R.M., Ordovas J.M., et al. The ABCG5 polymorphism contributes to individual response to dietary cholesterol and carotenoids in eggs. J Nutr 136 (2006) 1161-1165